Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Ramipril prolongs life and is cost effective in chronic proteinuric nephropathies — Piero Ruggenenti (2001) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Ramipril prolongs life and is cost effective in chronic proteinuric nephropathies
Shared by
Giuseppe Remuzzi
Ramipril prolongs life and is cost effective in chronic proteinuric nephropathies
Article
2001
en
Authors
+3 more
PR
Piero Ruggenenti
EP
Eva Pagano
LT
Luciana Tammuzzo
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
1998
Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies
Piero Ruggenenti
,
Annalisa Perna
,
Lidia Mosconi
,
Roberto Pisoni
,
Giuseppe Remuzzi
Article
2005
Pathophysiology of disease progression in proteinuric nephropathies
Norberto Perico
,
Igor Codreanu
,
Arrigo Schieppati
,
Giuseppe Remuzzi
Article
2000
Chronic Proteinuric Nephropathies. II. Outcomes and Response to Treatment in a Prospective Cohort of 352 Patients
Piero Ruggenenti
,
Annalisa Perna
,
Carmine Zoccali
,
Giulia Gherardi
,
Roberto Benini
,
A. Testa
,
Giuseppe Remuzzi
Article
2005
Is Regression of Chronic Nephropathies a Therapeutic Target?
Giuseppe Remuzzi
,
Andrea Remuzzi
Article
2000
Chronic proteinuric nephropathies: Outcomes and response to treatment in a prospective cohort of 352 patients with different patterns of renal injury
Piero Ruggenenti
,
Annalisa Perna
,
Giulia Gherardi
,
Roberto Benini
,
Giuseppe Remuzzi
.webp){kind=small}
Discussion(0)
No comments yet. Be the first to comment.